Ironwood Pharma (IRWD) Misses Q2 EPS by 2c

Ironwood Pharma (NASDAQ: IRWD) reported Q2 EPS of ($0.38), $0.02 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $6.84 million versus the consensus estimate of $15.75 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
• Primis Financial (FRST) Misses Q1 EPS by 8c
• USCB Financial Holdings, Inc. (USCB) Tops Q1 EPS by 2c